Monday, August 3, 2020

Aim to list Biocon Biologics on capital markets by 2023: CFO MB Chinappa

Aim to list Biocon Biologics on capital markets by 2023: CFO MB Chinappa Biocon Biologics has raised $105 million so far this calendar year through two primary equity infusions.

from Moneycontrol Business News https://ift.tt/3k8v6Ue

No comments:

Post a Comment

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...